Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
A 753-P: Tirzepatide improves HRQoL compared with insulin lispro in poorly controlled basal insulin-treated adults with long-standing T2D (SURPASS-6)
Not a drug, food, or cosmetic
Protecting the vial from light helps preserve potency
Home Metabolic Retatrutide (30mg) Metabolic Research Peptide GLP-1 / GIP / Glucagon triple-receptor agonist Research-grade, Australia In stock dispatched Australia-wide View & buy on store Retatrutide (development code LY3437943) is a synthetic triple-agonist peptide that acts on three metabolic receptor targets at once: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor
Other possible effects include mild headache, fatigue, and slight digestive changes
US$ 27.69
US$ 24.93
US$ 24.34
US$ 29.13
US$ 27.73
US$ 24.76
US$ 24.09
US$ 28.52
US$ 20.73
US$ 26.60
